Latest news for Electric Metals (USA) (OTC:EMUSF) Stock

Electric Metals (USA) Ltd is a U.S.-based mineral development company with manganese and silver projects to support the transition to clean energy. The Company's principal asset is the Emily Manganese Project in Minnesota, which has been the subject of considerable technical studies, including a National Instrument 43-101 Technical Report. Its mission in Minnesota is to become a domestic U.S. producer of high-purity, high-value manganese metal and chemical products for supply to U.S. energy, technology and industrial markets. With manganese plays a critical and prominent role in lithium-ion battery formulations, and with no current domestic supply or active mines for manganese in North America. The company operates in three geographical segments, Canada, the USA, and Australia.

ELECTRIC METALS USA LTD by ELECTRIC METALS USA LTD.

Electric Metals (USA) Ltd

Trading Ideas

LDTC

LeddarTech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 75.2%

Rosenblatt analyst Barton Crockett maintains Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) with a Neutral and raises the price target from $28 to $29.

News

Price Target

Analyst Ratings

SIRI

Rosenblatt Maintains Neutral on Sirius XM Holdings, Raises Price Target to $29

Expect a manufacturing revival and <a href="https://www.benzinga.com/news/small-cap">a small-cap resurgence in 2025</a>.
That&#8217;s according to Scott Helfstein, head of investment strategy at Global X ETF. After a grueling 23 months of contraction, &#8220;modest protectionist policy might help jump-start production,&#8221; he <a href="https://www.globalxetfs.com/global-x-2025-outlook/">says</a>.
<h2 class="wp-block-heading">Manufacturing: From Doldrums To Dynamo</h2>
Despite its diminished role compared to services, manufacturing still packs a $7 trillion punch—roughly 25% of GDP. Global X sees tariff policies and supply chain recalibrations as potential sparks for growth.
Here's the kicker: historical trends show even a 1% bump in tariffs can lead to a 0.2% boost in new orders and longer work hours. Expanding business services will offset <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42421528/trumps-tariff-storm-3-survival-strategies-us-companies-are-using-to-fight-back">higher prices weighing on consumers</a>, Helfstein predicts.
The Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) provides investors with exposure to some of the top names in the industrial and manufacturing space.
Read Also: <a href="https://www.benzinga.com/24/11/41886697/two-ideas-famed-stock-market-forecasters-agree-on-for-2025">Why Trump&#8217;s Win Has 2 Market Experts Betting On Small Caps, Financials</a>
<h2 class="wp-block-heading">Small Caps: Ready To Run</h2>
Should <a href="https://www.benzinga.com/trading-ideas/small-cap-analysis">small-cap companies</a> return to prior spending levels, that could amount to $140 billion and a 4% lift to nonresidential private investment, Helfstein adds. 
Deregulation and improved business conditions could reignite their capital expenditures, he explains. So while these companies may not dominate headlines like their mega-cap peers, their ability to drive localized growth and market expansion is hard to ignore. 
Popular ETFs such as the iShares Core S&amp;P Small-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IJR#NYSE">IJR</a>), the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) and the Vanguard Small Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VB#NYSE">VB</a>) provide exposure to small-cap stocks in the U.S.
<h2 class="wp-block-heading">Valuations: Lofty, But Justified?</h2>
With the S&amp;P 500's forward price-to-earnings ratio sitting at a lofty 24x, skepticism is natural. But Global X argues this could be part of a lasting shift, fueled by record-high profit margins and companies doubling down on tech-driven efficiencies.
And here's the standout stat: 73% of the S&amp;P 500 is trading above its 200-day moving average. That&#8217;s a sign that market breadth is improving. Pair that with a manufacturing rebound and small-cap revival, and the path to broader participation looks clearer.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/space/24/12/42412982/russell-2000-high-flyers-4-stocks-shaping-2024-with-quantum-ai-nuclear-space">Russell 2000 High Flyers: 4 Stocks Shaping 2024 With Quantum, AI, Nuclear, Space</a></li>
</ul>
Image: Shutterstock

Long Ideas

Sector ETFs

Broad U.S. Equity ETFs

Small Cap Analysis

Small Cap

ETFs

Manufacturing Comeback? Strategist Expects Tariffs To Help Small-Cap Stocks But Weigh On Consumers

LiveOne Secures Multi-Year Music Deals With BMI And ASCAP, Restructures $8M In Payables As Part Of Strategic Initiatives

LAES

SEALSQ Shares Resume Trade

Rosenblatt analyst Hans Mosesmann maintains Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Buy and maintains $240 price target.

AVGO

Rosenblatt Maintains Buy on Broadcom, Maintains $240 Price Target

Deep-pocketed investors have adopted a bullish approach towards CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for CVS Health. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 44% bearish. Among these notable options, 6 are puts, totaling $904,367, and 3 are calls, amounting to $88,505.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $52.5 to $75.0 for CVS Health over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of CVS Health stands at 1951.75, with a total volume reaching 1,669.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in CVS Health, situated within the strike price corridor from $52.5 to $75.0, throughout the last 30 days.
<h3>CVS Health Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733928472_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$22.2</td>
<td>$22.15</td>
<td>$22.2</td>
<td>$75.00</td>
<td>$466.2K</td>
<td>273</td>
<td align="right">210</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$17.15</td>
<td>$16.95</td>
<td>$16.95</td>
<td>$70.00</td>
<td>$152.5K</td>
<td>131</td>
<td align="right">90</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.0</td>
<td>$4.7</td>
<td>$4.75</td>
<td>$57.50</td>
<td>$143.8K</td>
<td>11.1K</td>
<td align="right">465</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/24/25</td>
<td>$6.45</td>
<td>$4.6</td>
<td>$4.6</td>
<td>$57.00</td>
<td>$81.4K</td>
<td>157</td>
<td align="right">179</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$9.1</td>
<td>$8.85</td>
<td>$8.95</td>
<td>$60.00</td>
<td>$34.9K</td>
<td>989</td>
<td align="right">70</td>
</tr>
</tbody>
</table>

<h3>About CVS Health</h3>
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
In light of the recent options history for CVS Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of CVS Health</h3>
<ul>
<li>Currently trading with a volume of 487,878, the CVS's price is down by -2.86%, now at $53.58. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 56 days.</li>
</ul>
<h3>What Analysts Are Saying About CVS Health</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $67.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on CVS Health with a target price of $58. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on CVS Health, maintaining a target price of $64. 
&#x2A; An analyst from TD Cowen persists with their Buy rating on CVS Health, maintaining a target price of $80. 
&#x2A; An analyst from Deutsche Bank upgraded its action to Buy with a price target of $66. 
&#x2A; In a cautious move, an analyst from Truist Securities downgraded its rating to Buy, setting a price target of $67. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest CVS Health options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

What the Options Market Tells Us About CVS Health

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly.
Looking at options history for Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 27% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $161,203 and 7, calls, for a total amount of $504,204.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $400.0 to $920.0 for Eli Lilly during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $400.0 to $920.0 in the last 30 days. 
<h3>Eli Lilly Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733928467_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$83.2</td>
<td>$79.5</td>
<td>$79.5</td>
<td>$800.00</td>
<td>$151.0K</td>
<td>345</td>
<td align="right">29</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$65.05</td>
<td>$62.55</td>
<td>$63.32</td>
<td>$840.00</td>
<td>$107.7K</td>
<td>606</td>
<td align="right">17</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$398.45</td>
<td>$392.45</td>
<td>$397.55</td>
<td>$400.00</td>
<td>$79.5K</td>
<td>374</td>
<td align="right">0</td>
</tr>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$80.5</td>
<td>$79.5</td>
<td>$80.5</td>
<td>$800.00</td>
<td>$64.4K</td>
<td>345</td>
<td align="right">2</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$55.1</td>
<td>$52.3</td>
<td>$53.35</td>
<td>$830.00</td>
<td>$53.3K</td>
<td>1.0K</td>
<td align="right">1</td>
</tr>
</tbody>
</table>

<h3>About Eli Lilly</h3>
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
After a thorough review of the options trading surrounding Eli Lilly, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Eli Lilly</h3>
<ul>
<li>Trading volume stands at 120,979, with LLY's price down by -0.54%, positioned at $795.24.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 55 days.</li>
</ul>
<h3>Expert Opinions on Eli Lilly</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $998.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Wolfe Research lowers its rating to Outperform with a new price target of $1000. 
&#x2A; An analyst from B of A Securities has revised its rating downward to Buy, adjusting the price target to $997. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Eli Lilly options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Eli Lilly Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MU, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for Micron Technology.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 30%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $92,000, and 9, calls, for a total amount of $375,057.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $60.0 to $120.0 for Micron Technology over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Micron Technology's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Micron Technology's significant trades, within a strike price range of $60.0 to $120.0, over the past month.
<h3>Micron Technology Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733928462_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$9.3</td>
<td>$9.1</td>
<td>$9.2</td>
<td>$100.00</td>
<td>$91.9K</td>
<td>5.1K</td>
<td align="right">0</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$7.35</td>
<td>$7.25</td>
<td>$7.28</td>
<td>$110.00</td>
<td>$72.8K</td>
<td>10.0K</td>
<td align="right">100</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$13.75</td>
<td>$11.35</td>
<td>$12.2</td>
<td>$89.00</td>
<td>$61.0K</td>
<td>16</td>
<td align="right">50</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.15</td>
<td>$5.05</td>
<td>$5.15</td>
<td>$105.00</td>
<td>$51.3K</td>
<td>12.3K</td>
<td align="right">293</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$42.3</td>
<td>$38.25</td>
<td>$40.01</td>
<td>$60.00</td>
<td>$40.0K</td>
<td>24</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Micron Technology</h3>
Micron is one of the largest semiconductor companies in the world, specializing in memory and storage chips. Its primary revenue stream comes from dynamic random access memory, or DRAM, and it also has minority exposure to not-and or NAND, flash chips. Micron serves a global customer base, selling chips into data centers, mobile phones, consumer electronics, and industrial and automotive applications. The firm is vertically integrated.
After a thorough review of the options trading surrounding Micron Technology, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Micron Technology's Current Market Status</h3>
<ul>
<li>With a volume of 762,035, the price of MU is up 0.34% at $98.43. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 7 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Micron Technology with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Micron Technology Unusual Options Activity For December 11

Macro Economic Events

Macro Notification

Global

Econ #s

Economics

General

Bank Of Canada Interest Rate Decision 3.25% Vs 3.25% Est.; 3.75% Prior

<a href="https://www.benzinga.com/general/24/04/38073344/mark-cuban-predicts-worlds-first-trillionaire-wont-be-musk-or-bezos-itll-be-someone-who-masters-ai-a">Artificial intelligence is everywhere</a> right now. From classrooms to health care, it's making many people excited – and just as nervous. Sure, it can write poems and summarize meetings, but what happens when it starts replacing jobs? That's a question no one seems to want to dig into too deeply. We're all standing on the edge of a pool, wondering if the water's warm or icy but too scared to jump in and find out.
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
In a September 2024 interview on The Today Show, <a href="https://www.benzinga.com/personal-finance/24/11/41882910/bill-gates-shares-the-best-investment-for-getting-rich-if-youre-earning-100000-or-less-but-wall-street-might-not-agree">Bill Gates</a>, cofounder of Microsoft and one of the world's loudest tech visionaries, dove into that pool. Promoting his new Netflix series, What's Next: The Future with Bill Gates, he didn't shy away from the elephant in the room: AI's impact on the workforce and, ultimately, on society itself.
Gates started by sharing some exciting ways AI is already being used. "In Newark, I've seen it being piloted in classrooms to enhance education. It's also simplifying health care, like sorting out medical bills or helping doctors with MRIs." Sounds promising, right? But then he dropped this: "When we had tractors, okay, farmers can do other things. But here, we're talking about almost every kind of job being affected."&nbsp;
See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
According to Gates, this monumental shift in the workforce could lead to more leisure time. Great, in theory. But then what? "It's going to create almost a, ‘Wow, what do we do with all that time?' type problem," he said. In other words, AI might give us the time we've always dreamed of but leave us struggling to figure out how to use it.
That's just one of the paradoxes he touched on. Gates admitted that experts don't fully understand how AI makes decisions. "It's so powerful. It's advancing faster than anything we've seen before," he said. "And with that comes a need for regulation." He called for governments to create rules to address AI risks – whether that's liability for bad advice or ensuring the tech doesn't amplify discrimination. But there's a catch: AI is moving so quickly that writing those rules is a nightmare.
Still, Gates isn't all doom and gloom. He's a fan of AI and even uses it himself. "Oh, yeah," he said. "I use it to summarize meetings, analyze books or draft speeches. It's incredibly time-saving and even creatively surprising – it can write poems and songs!"
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
So, is AI a dream or a disaster waiting to happen? Gates thinks it'll be both. "Mostly, it's going to bring good stuff," he said. "But the big question is, will we get it right?"
Whether AI makes your life easier, puts your job at risk or leaves you staring at a blank calendar wondering what to do with your day, one thing is clear – it's not going away. And while people like Gates are <a href="https://www.benzinga.com/personal-finance/24/11/41949050/bill-gates-warned-the-u-s-will-experience-another-2008-style-financial-crisis-he-cant-predict-when-but-says-this-is-a-certainty">asking the big questions</a>, the rest of us might want to start thinking about them, too.
The rapid rise of AI has many workers on edge. A 2023 survey by the American Psychological Association found that nearly four in 10 U.S. workers (38%) worry that AI could make some or all of their job duties obsolete.&nbsp;
This anxiety isn't limited to the U.S.; in India, a Microsoft survey revealed that 74% of workers fear AI will replace their jobs. Even younger employees aren't immune, with over half of 18 to 24-year-olds expressing concern about AI's impact on their future careers.&nbsp;
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a> </li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Bill Gates Predicts AI In The Workforce Will Lead To So Much 'Leisure Time'– But It'll Create A 'What Do We Do With All That Time?' Problem

Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) has outperformed the market over the past 5 years by 23.14% on an annualized basis producing an average annual return of 36.78%. Currently, Howmet Aerospace has a market capitalization of $46.89 billion. 
Buying $100 In HWM: If an investor had bought $100 of HWM stock 5 years ago, it would be worth $474.63 today based on a price of $115.42 for HWM at the time of writing.
<h3>Howmet Aerospace's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733928309_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Howmet Aerospace 5 Years Ago Would Be Worth This Much Today

RTX Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) disclosed the successful live-firing of its High-Energy Laser Weapon System (HELWS) with the British Army, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/n42430737/rtxs-raytheon-high-energy-laser-weapon-system-fired-by-british-army-for-first-time" rel="noreferrer noopener">effectively targeting moving aerial threats</a>.
This experiment marks the British Army&#8217;s first test of a high-energy laser weapon mounted on an armored vehicle, with soldiers trained on the weapon&#8217;s targeting and tracking technologies.
Raytheon&#8217;s HELWS is the first laser weapon integrated and fired from a land vehicle in the UK, part of a collaborative program between Raytheon UK and Team Hersa, the joint LDEW initiative involving Defence and Science Laboratory and Defence Equipment and Support.
The trial, held at a military range in Wales, marked the latest phase of the U.K. Ministry of Defence&#8217;s Land Laser Directed Energy Weapon (LDEW) demonstrator program.
&#8220;Our High-Energy Laser Weapon System has been used in operations globally, and now the British Army is experimenting with this game-changing capability,&#8221; said&nbsp;James Gray, chief executive and managing director of Raytheon UK.
Matt Cork, Head of Team Hersa, added, &#8220;By integrating advanced directed energy technologies onto armoured platforms, we&#8217;re not only proving the feasibility of these game-changing systems but also accelerating their path to operational readiness. It&#8217;s an exciting step forward in redefining the future of defence capability.&#8221;
Investors can gain exposure to the stock via iShares U.S. Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) and Global X Funds Global X Defense Tech ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHLD#NYSE">SHLD</a>).
Price Action: RTX shares are down 0.18% at $117.40 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42382786/morgan-stanley-narrows-down-winning-and-losing-bets-in-the-first-100-days-of-trump-administration" target="_blank" rel="noreferrer noopener">Morgan Stanley Narrows Down Winning And Losing Bets In The First 100 Days Of Trump Administration</a></li>
</ul>

Equities

Large Cap

Contracts

iShares Dow Jones US Aerospace & Defense Index Fund

SHLD

Raytheon's High-Energy Laser Weapon System Tested With British Army: Details

SEALSQ Shares Halted On Circuit Breaker To The Upside, Stock Now Up 134.7%

Rosenblatt analyst Hans Mosesmann maintains Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) with a Buy and maintains $85 price target.

LSCC

Rosenblatt Maintains Buy on Lattice Semiconductor, Maintains $85 Price Target

LeddarTech Shares Resume Trade

D. Boral Capital analyst Jason Kolbert maintains Enlivex Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENLV#NASDAQ">ENLV</a>) with a Buy and maintains $13 price target.

ENLV

D. Boral Capital Maintains Buy on Enlivex Therapeutics, Maintains $13 Price Target

Market Summary

$BTC

Benzinga Market Summary: CPI Figures In Line With Estimates, Bitcoin Rises, Kroger-Albertsons Deal Terminated

The <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42404450/bitcoin-ethereum-dogecoin-recover-losses-after-flash-crash-analyst-pinpoints-critical-btc-su">cryptocurrency market&#8217;s recent volatility</a> has prompted a reassessment of key indicators, suggesting that the current bull run may still have significant room for growth, according to a comprehensive analysis shared on X.
What Happened: Despite recent market turbulence, described as &#8220;the biggest liq flush since 2021,&#8221; the analysis paints a bullish picture for the crypto market&#8217;s future, opening with the words &#8220;don&#8217;t think we&#8217;re anywhere near a top.&#8221;
The <a href="https://x.com/cryptoklotz/status/1866506875891576938">thread</a>, posted by a crypto analyst on Tuesday, examines four crucial aspects: 
Funnie pointed to the largest liquidity flush since 2021 over the past three weeks and detailed four core areas supporting his conviction: Despite growing nervousness in the market, the signals across on-chain metrics, regulatory developments, macro conditions, and market cap trends remain strongly bullish.
<ol>
<li>On-Chain Metrics: indicators such as the Puell Multiple and Pi Cycle Top suggest the market is still in a healthy growth phase. Most metrics indicate that we are nowhere near a top, with key resistance levels in the market structure holding firm.</li>
<li>Altcoin Consolidation: altcoins remain below previous all-time highs, similar to patterns seen in December 2020 and February 2021, preceding major breakouts. For example, Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) remains below its previous high of $4,800, still shy of an inflation-adjusted target of $6,000. Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) is stabilizing in the low $200s, with open interest resetting to lows, signaling potential for another leg up.</li>
<li>Macro and Regulatory Tailwinds: a historic shift toward <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42422705/donald-trump-would-welcome-150000-bitcoin-early-in-presidency-its-another-stock-market-for-him">pro-crypto sentiment</a>, underscored by Federal Reserve Chair Jerome Powell&#8216;s <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42325788/fed-chair-powell-bitcoin-is-like-gold-just-virtual-and-digital">acknowledgment of Bitcoin</a> as "digital gold," adds to market optimism. Favorable interest rate policies and liquidity tailwinds further strengthen the market environment.</li>
<li>Market Structure: the overall structure mirrors December 2020's bullish setup, suggesting another potential rally before any major correction.</li>
</ol>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42433831/bitcoin-to-200000-ethereum-to-7000-solana-to-750-in-2025-predicts-bitwise">Bitcoin To $200,000, Ethereum To $7,000, Solana To $750 In 2025, Predicts Bitwise</a>
Why It Matters: The analyst estimates the likelihood of this cycle topping at less than 1%, with cold on-chain indicators, accelerating regulatory progress, and supportive macroeconomic conditions providing strong backing. 
He advises traders to remain confident but to manage risk effectively, noting that the market is likely setting up for another significant move.
"This is a time to stay convicted—not wobbly," the report concludes, urging traders to avoid letting short-term fear cloud <a href="https://www.benzinga.com/money/bitcoin-price-prediction">long-term opportunities</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42024635/scaramucci-trumps-crypto-support-could-push-bitcoin-to-150k">Scaramucci: Trump&#8217;s Crypto Support Could Push Bitcoin To $150K</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$ETH

$SOL

What Bitcoin Crash? 'Don't Think We're Anywhere Near A Top,' Analyst Reassures

CNCKW

Trading Halt: Halt status updated at 9:40:00 AM ET: Quotation Resumption: New Issue Available

Electric Metals (USA) appoints Brian Savage as president and CEO

Electric Metals announces private placement offering

EMUSF

Legal

Press Releases

Electric Metals Files the Upgraded Emily,  Minnesota Manganese Project NI 43-101 Technical Report Confirming the Highest Grade Manganese Resource in North America

Presenting on the Emerging Growth Metals Mining Resources & Energy Conference on May 29 Register Now

Management

Electric Metals (USA) Limited Further Strengthens its Board of Directors

Electric Metals (USA) Announces Results of Annual Shareholder Meeting

Events

Electric Metals (USA) Will Attend the Battery & Precious Metals Virtual Investor Conference

Electric Metals Announces Changes to its Board of Directors

Metallurgical Tests Yield High-Purity Manganese Sulfate Monohydrate from the Emily Manganese Deposit, Minnesota

Comments

Electric Metals (USA)

News

Latest news for Electric Metals (USA) (OTC:EMUSF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga